Search Results - Gayford, Dawn

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Circulating interleukin‐6 as a biomarker in a randomized controlled trial of modified‐release prednisone vs immediate‐release prednisolone, in newly diagnosed patients with giant cell arteritis

    Circulating interleukin‐6 as a biomarker in a randomized controlled trial of modified‐release prednisone vs immediate‐release prednisolone, in newly diagnosed patients with giant c... by Miler, Emma, Stapleton, Philip P., Mapplebeck, Sarah, Mackerness, Craig, Gayford, Dawn, Aung, Tin, Wilson, Lisa, Schofield, Paul, Dasgupta, Bhaskar

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    A 26‐week feasibility study comparing the efficacy and safety of modified‐release prednisone with immediate‐release prednisolone in newly diagnosed cases of giant cell arteritis

    A 26‐week feasibility study comparing the efficacy and safety of modified‐release prednisone with immediate‐release prednisolone in newly diagnosed cases of giant cell arteritis... by Raine, Charles, Stapleton, Philip P., Merinopoulos, Dimos, Maw, Win Win, Achilleos, Katerina, Gayford, Dawn, Mapplebeck, Sarah, Mackerness, Craig, Schofield, Paul, Dasgupta, Bhaskar

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: